Sahl Khalid Bedri

About me
Publications
CV
Public outreach and news

Research

Based on the up to date multiple sclerosis (MS) genetics information and our
expertise on the field we are working on a project to identify biomarkers for
MS treatment and outcome. On another project, we are studying novel genetic
variations in MS.

Articles

Article: ANNALS OF NEUROLOGY. 2022;91(3):417-423
Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
McKay KA; Bedri SK; Manouchehrinia A; Stawiarz L; Olsson T; Hillert J; Fink K
Article: SCIENTIFIC REPORTS. 2021;11(1):14987
Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study.
Karrenbauer VD; Bedri SK; Hillert J; Manouchehrinia A
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:666114
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases
Kharlamova N; Dunn N; Bedri SK; Jerling S; Almgren M; Faustini F; Gunnarsson I; Ronnelid J; Pullerits R; Gjertsson I; Lundberg K; Manberg A; Pin E; Nilsson P; Hober S; Fink K; Fogdell-Hahn A
Article: JOURNAL OF IMMUNOLOGY. 2019;203(4):888-898
IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis
Lindahl H; Guerreiro-Cacais AO; Bedri SK; Linnerbauer M; Linden M; Abdelmagid N; Tandre K; Hollins C; Irving L; Glover C; Jones C; Alfredsson L; Ronnblom L; Kockum I; Khademi M; Jagodic M; Olsson T
Article: PLOS ONE. 2019;14(5):e0217208
Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
Bedri SK; Nilsson OB; Fink K; Manberg A; Hamsten C; Ayoglu B; Manouchehrinia A; Nilsson P; Olsson T; Hillert J; Gronlund H; Glaser A
Article: CLINICAL IMMUNOLOGY. 2018;187:15-25
Multiple sclerosis treatment effects on plasma cytokine receptor levels
Bedri SK; Fink K; Manouchehrinia A; Lundstrom W; Kockum I; Olsson T; Hillert J; Glaser A
Article: HUMAN MOLECULAR GENETICS. 2015;24(19):5644-5654
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis
Gu BJ; Field J; Dutertre S; Ou A; Kilpatrick TJ; Lechner-Scott J; Scott R; Lea R; Taylor BV; Stankovich J; Butzkueven H; Gresle M; Laws SM; Petrou S; Hoffjan S; Akkad DA; Graham CA; Hawkins S; Glaser A; Bedri SK; Hillert J; Matute C; Antiguedad A; Wiley JS
Article: BRAIN. 2015;138(Pt 3):632-643
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
Goris A; Pauwels I; Gustavsen MW; van Son B; Hilven K; Bos SD; Celius EG; Berg-Hansen P; Aarseth J; Myhr K-M; D'Alfonso S; Barizzone N; Leone MA; Boneschi FM; Sorosina M; Liberatore G; Kockum I; Olsson T; Hillert J; Alfredsson L; Bedri SK; Hemmer B; Buck D; Berthele A; Knier B; Biberacher V; van Pesch V; Sindic C; Oturai AB; Sondergaard HB; Sellebjerg F; Jensen PEH; Comabella M; Montalban X; Perez-Boza J; Malhotra S; Lechner-Scott J; Broadley S; Slee M; Taylor B; Kermode AG; Gourraud P-A; Sawcer SJ; Andreassen BK; Dubois B; Harbo HF
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2015;22(2):328-333
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Sundal C; Baker M; Karrenbauer V; Gustavsen M; Bedri S; Glaser A; Myhr K-M; Haugarvoll K; Zetterberg H; Harbo H; Kockum I; Hillert J; Wszolek Z; Rademakers R; Andersen O

All other publications

Thesis / dissertation: 2019
Multiple sclerosis : from genetic variants to biomarkers
Bedri, Sahl Khalid

Employments

Affiliated to Research, Department of Clinical Neuroscience, Karolinska Institutet, 2022-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2020

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI